Stay Ahead of Compliance with Monthly Citation Updates


In your State Survey window and need a snapshot of your risks?

Survey Preparedness Report

One Time Fee
$79
  • Last 12 months of citation data in one tailored report
  • Pinpoint the tags driving penalties in facilities like yours
  • Jump to regulations and pathways used by surveyors
  • Access to your report within 2 hours of purchase
  • Easily share it with your team - no registration needed
Get Your Report Now →

Monthly citation updates straight to your inbox for ongoing preparation?

Monthly Citation Reports

$18.90 per month
  • Latest citation updates delivered monthly to your email
  • Citations organized by compliance areas
  • Shared automatically with your team, by area
  • Customizable for your state(s) of interest
  • Direct links to CMS documentation relevant parts
Learn more →

Save Hours of Work with AI-Powered Plan of Correction Writer


One-Time Fee

$49 per Plan of Correction
Volume discounts available – save up to 20%
  • Quickly search for approved POC from other facilities
  • Instant access
  • Intuitive interface
  • No recurring fees
  • Save hours of work
F0757
D

Failure to Monitor Blood Pressure as Ordered for Antihypertensive Medications

Crownsville, Maryland Survey Completed on 09-17-2025

Penalty

No penalty information released
tooltip icon
The penalty, as released by CMS, applies to the entire inspection this citation is part of, covering all citations and f-tags issued, not just this specific f-tag. For the complete original report, please refer to the 'Details' section.

Summary

A deficiency was identified when a resident's drug regimen was not kept free from unnecessary drugs due to a failure to monitor blood pressure as required by physician orders. The resident, admitted for rehabilitation with diagnoses including paralytic syndrome following cerebral infarction, hypertension, and other conditions, was prescribed three blood pressure medications: Isosorbide Mononitrate, Lisinopril, and Hydralazine. All three medications had physician-ordered parameters to hold administration if the blood pressure reading was less than 100. While the Medication Administration Record (MAR) showed blood pressure monitoring at 9 AM for Lisinopril, there was no documentation of blood pressure readings for the 2 PM and 9 PM doses of Hydralazine. Further review of the electronic medical record's vital sign section revealed inconsistencies in recording blood pressures at the times Hydralazine was administered in the afternoon and evening. During an interview, the RN unit manager and the Assistant Director of Nursing confirmed that the MAR did not include a space to record blood pressure readings for all medications requiring such monitoring, corroborating the surveyor's findings.

An unhandled error has occurred. Reload 🗙